awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34095821-8B134CFC-6596-4E10-A019-9AEF7FA2871F
Q34095821-8B134CFC-6596-4E10-A019-9AEF7FA2871F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34095821-8B134CFC-6596-4E10-A019-9AEF7FA2871F
Is Higher Efficacy Always at the Price of More Side Effects during Chemotherapy?
P2860
Q34095821-8B134CFC-6596-4E10-A019-9AEF7FA2871F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34095821-8B134CFC-6596-4E10-A019-9AEF7FA2871F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11f4d2fe250271e9ed77f4161147ea6b4b73f854
P2860
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.